$EVC

ENTRAVISION COMMUNICATIONS CORP

No enriched coverage for $EVC in the last 7 days.

No SEC Form 4 filings for $EVC in the last 30 days.

Med

EVC - Entravision Communications Cp Latest Stock News & Market Updates

This page provides news and market updates for Entravision Communications Corporation (EVC), a media and advertising technology company. It covers financial results, strategic initiatives such as expanding sales and integrating AI, capital structure updates, and community engagement. Recent news highlights include Q3 2025 financial results showing strong Advertising Technology & Services growth, a new PSA campaign for Latino voter participation, and a strategic amendment to its credit agreement to enhance financial stability.

Morgan Stanley Upgrades DexCom (DXCM), Cites Undervalued Recovery and G7 Margin Potential

Morgan Stanley upgraded DexCom (DXCM) to Overweight with a $75 price target, citing an undervalued recovery and G7 rollout margin potential. This upgrade comes despite Evercore ISI initiating coverage with an In Line rating due to anticipated headwinds like product quality concerns and competitive threats. Separately, DexCom announced FDA clearance for Dexcom Smart Basal, a CGM-integrated basal insulin dosing optimizer for Type 2 diabetes patients.